PIPE-791 Dose A
CTX-791-201
Phase 2 small_molecule active
Quick answer
PIPE-791 Dose A for Idiopathic Pulmonary Fibrosis is a Phase 2 program (small_molecule) at Contineum Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Contineum Therapeutics
- Indication
- Idiopathic Pulmonary Fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active